On June 11-14, SRF representatives attended the 2025 EULAR Congress in Barcelona, Spain, to raise awareness about CONQUEST—the global clinical trial created by the SRF to accelerate the development of potential new treatments for scleroderma.
The SRF’s CONQUEST leadership team was represented by Gregory Gordon, MD, JD, Chief Medical Officer of the SRF; Luke Evnin, PhD, Chairman; and Dinesh Khanna, MD, Co-Chair of the CONQUEST Steering Committee. During the event, the SRF also hosted a CONQUEST reception.
The European Alliance of Associations for Rheumatology (EULAR) Congress is an international gathering that fosters scientific, educational, and clinical exchange in the field of rheumatology. The SRF is committed to engaging in key forums like this to elevate awareness of scleroderma within the global rheumatology community.
